NCT05129969
Registry Platform Ovarian and Endometrial Cancer No drug interventions Not Available Not Available recruiting NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT05012397
Milademetan in Advanced/Metastatic Solid Tumors treatment 2 terminated NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) screening 2 active_not_recruiting NCT03604315
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF No drug interventions treatment 1 recruiting NCT04310826
Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy No drug interventions prevention Not Available active_not_recruiting NCT05773859
NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer No drug interventions treatment 1 / 2 recruiting NCT06028932
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients treatment 2 recruiting NCT06264921
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT06422455
Access to Genetic Testing in Underserved Patients With Cancer No drug interventions health_services_research Not Available not_yet_recruiting NCT06546553
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. treatment 1 recruiting NCT04851119
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors treatment 1 / 2 recruiting NCT06611072
ACTivating the Immune Response in Ovarian CaNcer No drug interventions other Not Available not_yet_recruiting NCT06299163
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06586957
A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT05261490
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer treatment 1 / 2 terminated NCT03150121
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage No drug interventions diagnostic Not Available recruiting NCT02244502
Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) treatment 1 / 2 unknown_status NCT03302884
Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma No drug interventions basic_science Not Available unknown_status NCT06321484
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer treatment 1 not_yet_recruiting NCT05311579
Niraparib Plus Anlotinib for Recurrent Ovarian Cancer treatment 2 unknown_status NCT02194387
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members No drug interventions prevention Not Available active_not_recruiting NCT01709487
Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy No drug interventions treatment 1 / 2 completed NCT03562533
Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer Not Available Not Available completed NCT05180851
Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study treatment 0 unknown_status NCT01657747
Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer No drug interventions diagnostic Not Available completed NCT00756847
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors treatment 1 completed NCT05001347
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors treatment 2 completed NCT04257045
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives No drug interventions Not Available Not Available completed NCT02166905
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission treatment 1 / 2 completed NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT06475261
Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy No drug interventions Not Available Not Available not_yet_recruiting NCT02708511
Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer diagnostic 1 terminated NCT06290193
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Primary Cytoreductive Surgery No drug interventions treatment 2 recruiting NCT02487693
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma No drug interventions treatment 2 active_not_recruiting NCT00488878
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors No drug interventions Not Available Not Available recruiting NCT02584478
Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) treatment 3 active_not_recruiting NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 2 recruiting NCT00853307
MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma treatment 2 completed NCT02025985
Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies treatment 2 completed NCT00047632
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer diagnostic 3 terminated NCT04251052
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT02073500
Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies No drug interventions Not Available Not Available recruiting NCT05446870
Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) treatment 2 active_not_recruiting NCT02530606
Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer No drug interventions diagnostic Not Available withdrawn NCT00892736
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy treatment 1 completed NCT02335918
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors treatment 1 / 2 completed NCT05927818
Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer No drug interventions diagnostic Not Available recruiting NCT04602117
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer treatment 1 withdrawn NCT02412124
Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers No drug interventions supportive_care Not Available terminated NCT00214058
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer treatment 2 completed NCT00154986
IGFBP-3 in Ovarian Cancer Invasion No drug interventions diagnostic Not Available unknown_status NCT03085225
Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. treatment 1 completed NCT03382574
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy prevention 0 terminated NCT01936974
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma treatment 2 terminated NCT03372720
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors No drug interventions supportive_care Not Available completed NCT05001282
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) No drug interventions treatment 1 / 2 terminated NCT00623831
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen No drug interventions treatment 1 completed NCT01312376
Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer treatment 1 terminated NCT03379376
EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery No drug interventions supportive_care Not Available completed NCT05591560
Itraconazole in Advanced Ovarian Cancer treatment Not Available not_yet_recruiting NCT03180294
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer supportive_care 2 completed NCT01696994
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) No drug interventions screening Not Available active_not_recruiting NCT02878980
An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients No drug interventions supportive_care Not Available withdrawn NCT05494580
Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer treatment 1 / 2 recruiting NCT01295489
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer No drug interventions Not Available Not Available completed NCT01907789
Prophylactic Salpingectomy With Delayed Oophorectomy No drug interventions prevention Not Available active_not_recruiting NCT00868192
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma treatment 2 completed NCT01366144
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction treatment 1 active_not_recruiting NCT00181701
Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin treatment 2 completed NCT01481701
A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma treatment 2 completed NCT05610501
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses. No drug interventions Not Available Not Available recruiting NCT01519869
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma No drug interventions treatment 2 completed NCT03965481
PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT02595281
HE4 as a Relapse Biomarker in Ovarian Cancers No drug interventions diagnostic Not Available completed NCT00305695
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries supportive_care 2 completed NCT02419495
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies treatment 1 active_not_recruiting NCT01689714
Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma No drug interventions other 2 completed NCT00862355
Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer No drug interventions other 1 completed NCT06393543
International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis No drug interventions Not Available Not Available not_yet_recruiting NCT00721890
Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma No drug interventions Not Available 2 completed NCT05200364
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer treatment 1 active_not_recruiting NCT02124421
HOT: HIPEC in Ovarian Cancer as Initial Treatment treatment 2 active_not_recruiting NCT02218502
Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses No drug interventions diagnostic Not Available terminated NCT03027479
Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss No drug interventions health_services_research Not Available completed NCT00445887
Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer prevention 2 completed NCT03857087
68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer Not Available Not Available completed NCT00989651
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT06285097
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors treatment 1 recruiting NCT00679783
Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer treatment 2 completed NCT06216561
Intraperitoneal LSTA1 in CRS-HIPEC treatment 1 withdrawn NCT01091428
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer treatment 2 completed NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT02578888
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies No drug interventions supportive_care Not Available completed NCT03029585
Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer treatment 2 terminated NCT06543537
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer No drug interventions health_services_research Not Available not_yet_recruiting NCT01445275
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 No drug interventions Not Available Not Available withdrawn NCT05429970
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) prevention Not Available recruiting NCT06492070
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers supportive_care 2 recruiting NCT00659399
Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression treatment 1 withdrawn NCT05714306
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma treatment 1 / 2 not_yet_recruiting NCT02083536
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma treatment 1 withdrawn NCT03756818
TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT05576519
Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma No drug interventions Not Available Not Available recruiting NCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing No drug interventions Not Available Not Available recruiting NCT05949424
OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults treatment 4 not_yet_recruiting NCT03839524
A Trial Evaluating TG4050 in Ovarian Carcinoma. No drug interventions treatment 1 active_not_recruiting NCT03957096
A Safety Study of SGN-CD47M in Patients With Solid Tumors No drug interventions treatment 1 terminated NCT04997096
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy No drug interventions supportive_care Not Available recruiting NCT02297958
Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma No drug interventions Not Available Not Available completed NCT05194735
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors treatment 1 / 2 active_not_recruiting NCT03748186
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers treatment 1 completed NCT00715286
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study No drug interventions treatment 3 unknown_status NCT03296826
Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2 No drug interventions Not Available Not Available recruiting NCT04442126
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 terminated NCT06295965
Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers, CHANCES Study No drug interventions Not Available Not Available recruiting NCT02584465
REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression treatment 2 completed NCT02345265
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer treatment 2 active_not_recruiting NCT04905082
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics No drug interventions supportive_care Not Available active_not_recruiting NCT04686682
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors No drug interventions treatment 1 / 2 recruiting NCT03842982
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI) No drug interventions treatment 3 recruiting NCT06420973
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression treatment 2 recruiting NCT05415527
Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management No drug interventions prevention Not Available recruiting NCT04147494
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues No drug interventions basic_science 0 recruiting NCT04878094
A Study of Intra-operative Imaging in Women With Ovarian Cancer No drug interventions diagnostic 3 recruiting NCT00183794
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma treatment 2 completed NCT04628780
Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT02159989
Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery treatment 1 completed NCT05310344
Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer treatment 2 unknown_status NCT04917744
Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors No drug interventions Not Available Not Available active_not_recruiting NCT04902144
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach No drug interventions screening Not Available completed NCT01175772
Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy treatment 2 terminated NCT00474669
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel treatment 1 completed NCT02315469
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery No drug interventions Not Available Not Available completed NCT06580314
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer treatment 3 not_yet_recruiting NCT00312650
Doxil and Gemcitabine in Recurrent Ovarian Cancer treatment 2 terminated NCT04562623
Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma No drug interventions Not Available Not Available recruiting